Clinical Trials

BioFuture™ 2024 Wraps Up: Hundreds of High-Profile Attendees Joined Recor

BPGbio to Present New Data on Novel Glioblastoma Therapies at SNO 2024

NewBiologix Launches Xcell™ rAAV Production and Analytics Platform to Imp

FDA Approves Novocure’s Innovative HFE Transducer Arrays for Use With Opt

Precision BioSciences to Participate in Upcoming November Investor Conferen

Cellino Hosts Second Annual Personalized RegenMed Forum to Accelerate Progr

Eikon Therapeutics Announces Appointment of Michael Klobuchar as Chief Oper

BPGbio Recognized as 2024 'BioTech AI Company of the Year' by BioTech Break

Lantern Pharma Announces First Patient Dosed in Japan for The Expansion Coh

Schrödinger Broadens and Accelerates Predictive Toxicology Initiative

Vizient Launches Capital Spend Insights to Simplify and Optimize Capital Eq

Simulations Plus and the University of Connecticut Receive New FDA Grant to

Healx announces agreement with Sanofi to seek new rare disease indications

nference Establishes AI Research Partnership with Parabilis Medicines in Co

New Medable AI Capabilities Simplifies Digital Clinical Trial Launch with I

Bruker Corporation to Present at Upcoming Investor Conferences

Cardio Diagnostics Holdings, Inc. to Sponsor and Showcase AI-Powered Soluti

Koneksa Appoints Eric Luthi as Chief Business Officer

Harrow Partners with Asembia to Enhance Provider and Patient Experience Thr

Insulet Reports Third Quarter 2024 Revenue Increase of 26% Year-Over-Year (

BPGbio to Present Transformative Immuno-Oncology Research on BPM31510 and B